Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 268M | 9.8% |
| Gross Profit | 155M | 24% |
| Cost of Revenue | 113M | 5.2% |
| Operating expense | 25M | 88.3% |
| Net Income | 55M | 413.2% |
| EBITDA | 134M | 0% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 965M | 14.7% |
| Total Liabilities | 526M | 4.4% |
| Total Equity | 317M | 34.8% |
| Shares Outstanding | 7.2M | 8.8% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 100M | 265.1% |
| Cash from investing | -300,000 | 0% |
| Cash from financing | -30M | 93.5% |
EPS
Financial Highlights for Nutex Health in Q3 '25
Nutex Health reported a revenue of 268M, which is a 9.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 155M, marking a 24% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 113M, a -5.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 25M, showing a -88.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 55M, showing a 413.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 134M, showing a 0% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Nutex Health with growth in revenue, gross profit, and net income.
